Clinical Trials Directory

Trials / Unknown

UnknownNCT06097026

Role of Inhaled Nitric Oxide in Vascular Mechanics and Right Ventricular Function

Role of Inhaled Nitric Oxide in Vascular Mechanics and Right Ventricular Function Following Cardiac Surgery

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
54 (estimated)
Sponsor
Fernando Suarez Sipmann · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to evaluate the role of nitric oxide on pulmonary vasculature and right ventricular function in postoperative cardiac surgery patients.

Detailed description

This study will evaluate modifiable pathophysiological treatments for postoperative pulmonary hypertension and right ventricular dysfunction. One pharmacological, inhaled nitric oxide, and one non-pharmacological, the OLA strategy combining lung recruitment and stabilization with individually optimized positive end-expiratory pressure (PEEP) and the possible synergistic effects of both interventions on right ventricular performance. Apart from acting specifically on the pathophysiological mechanisms described, the combination of an OLA strategy and iNO may be particularly beneficial, as modification of pulmonary status by OLA may, in theory, enhance the effects of iNO by significantly increasing gas exchange area and thus alveolar ventilation. A number of closely related physiological variables will also be studied to better characterize the effects of both strategies and their combination. This may help to better establish the indication for iNO in cardiac surgery patients and improve our understanding of mechanisms that are also present in ARDS patients, albeit on a different scale. This is a prospective randomized controlled physiological prospective study to be performed in two hospitals. The intervention period is limited to the first 2 -3 hours postoperatively. A total of 54 patients will be recruited.

Conditions

Interventions

TypeNameDescription
PROCEDUREAlveolar recruitment maneuverProgressive pressure increase on the ventilator to recruit collapsed alveoli and improve pulmonary ventilation.
DRUGNitric OxideAdminister nitric oxide upon arrival from cardiac surgery and assess cardiac and pulmonary function afterwards.

Timeline

Start date
2023-11-22
Primary completion
2024-08-01
Completion
2024-12-01
First posted
2023-10-24
Last updated
2024-02-28

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT06097026. Inclusion in this directory is not an endorsement.